Literature DB >> 24060455

First-in-man randomized clinical trial of renal denervation for atrial arrhythmia raises concern.

Jan A Staessen, Yu Jin, Lutgarde Thijs, Alexandre Persu, Michel Azizi, Sverre Kjeldsen.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24060455     DOI： 10.1016/j.jacc.2013.07.095

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

1.  Renal Sympathetic Denervation - A Review of Applications in Current Practice.

Authors:  Vikas Kapil; Ajay K Jain; Melvin D Lobo
Journal:  Interv Cardiol       Date:  2014-03

2.  Treatment of atrial fibrillation in patients with enhanced sympathetic tone by pulmonary vein isolation or pulmonary vein isolation and renal artery denervation: clinical background and study design : The ASAF trial: ablation of sympathetic atrial fibrillation.

Authors:  Mark R de Jong; Annemiek F Hoogerwaard; Ahmet Adiyaman; Jaap Jan J Smit; Anand R Ramdat Misier; Jan-Evert Heeg; Boudewijn A A M van Hasselt; Isabelle C Van Gelder; Harry J G M Crijns; Ignacio Fernández Lozano; Jorge E Toquero Ramos; F Javier Alzueta; Borja Ibañez; José M Rubio; Fernando Arribas; José M Porres Aracama; Josep Brugada; Lluís Mont; Arif Elvan
Journal:  Clin Res Cardiol       Date:  2018-02-27       Impact factor: 5.460

Review 3.  Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states.

Authors:  Michael J McArdle; Emil M deGoma; Debbie L Cohen; Raymond R Townsend; Robert L Wilensky; Jay Giri
Journal:  J Am Heart Assoc       Date:  2015-03-23       Impact factor: 5.501

Review 4.  Renal denervation for the management of resistant hypertension.

Authors:  Hitesh C Patel; Carl Hayward; Vassilis Vassiliou; Ketna Patel; James P Howard; Carlo Di Mario
Journal:  Integr Blood Press Control       Date:  2015-12-03

5.  Rationale and design of the Investigator-Steered Project on Intravascular Renal Denervation for Management of Drug-Resistant Hypertension (INSPiRED) trial.

Authors:  Yu Jin; Lotte Jacobs; Marie Baelen; Lutgarde Thijs; Jean Renkin; Frank Hammer; Joelle Kefer; Thibault Petit; Peter Verhamme; Stefan Janssens; Peter Sinnaeve; Jean-Philippe Lengelé; Alexandre Persu; Jan A Staessen
Journal:  Blood Press       Date:  2014-04-17       Impact factor: 2.835
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.